Intrinsic Value
Supernus Pharmaceuticals, Inc. (SUPN)
$34.11
+0.37 (+1.10%)
Enterprise Value | 3,945.57 |
---|---|
Net Debt | -33.53 |
Equity Value | 3,979.09 |
Shares Outstanding | 55.51 |
Equity Value Per Share | 71.69 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt